Research advance of maytansinoid class antibody drug conjugatesZHOU Lei, ZHANG Guo-ning, WANG Ju-xian, WANG Yu-cheng2521-2530
Clinical research of anti-interleukin-17 antibody in the treatment of autoimmune diseasesWANG Ting, LIN Bi-rong, MA Ying2531-2536
Application of anti-PD-1/PD-L1 antibodies in cancer immunotherapyQIU Xue-jia, LIU Yong, PANG Guo-xun, DONG Zhan-jun2537-2541
Progress in research of the new lipoglycopeptide antimicrobial agents dalbavancin, oritavancin and telavancinTIE Yuan, LIU Lei2542-2549
Detection and control of host cell proteins in genetic engineering pharmaceuticalsWANG Zhi-ming2550-2557
Method development and validation for polysaccharide activation degree of Haemophilus influenzae type bWANG Zhen, CHU Zi-qing, LIU Xiao-lei, LIU Feng, MENG Bei-qian, WANG Zhen-ye, SUN Shu-xue2558-2561
Resaerch process of cationic nanosystems as non-viral carriers for genetic drugsLIANG Jin-kang, WU Zhi-ling, ZHANG Gui-jun2562-2568
Advances in long-acting technology in peptide deliveryCHENG Nian, HU Zhong-ping, YANG Fan, CHENG Xi-yao, SU Zheng-ding2574-2580
Enforceability of drug compulsory license according to the article 49 of Patent LawLIU Yi-sheng, TIAN Kan2581-2586